Inside AML challenges with Drs. Jabbour, Daver
Elias Jabbour, MD, and Naval Daver, MD, both of the University of Texas MD Anderson Cancer Center, discuss challenges in TP53-mutated acute myeloid
Leukemia
Acute Myeloid Leukemia
News
SOHO Insider Podcast
EHA 2025
Dr. Komrokji reports imetelstat data in high-EPO MDS from EHA 2025
Rami Komrokji, MD, of Moffitt Cancer Center in Tampa, Florida, presented an update at the 2025 European Hematology Association Congress in Milan on
2025 ASCO
Video Interviews
Latest COMMANDS analysis shows luspatercept is transformative in MDS
In this video interview, Guillermo Garcia-Manero, MD, chief of the section of myelodysplastic syndromes at the University of Texas MD Anderson Cancer Center,
18-IMCL
Lymphoma
Gut-linked microbes tied to survival in DLBCL
The presence of certain intratumoral microbes was linked to survival outcomes in diffuse large B-cell lymphoma (DLBCL), according to findings presented at ICML
18-IMCL
Cellular Therapy
Lymphoma
‘Boom Boom’ Radiotherapy approach may boost CAR T-cell responses
The combination of so-called “Boom Boom” radiotherapy prior to treatment with lisocabtagene maraleucel (liso-cel) was found to be safe, feasible, and effective, according
News
Dr. Nieto discusses phase I results of AFM13 in lymphoma
Yago Nieto, MD, PhD, a professor at the University of Texas MD Anderson Cancer Center, discusses the results of AFM13 in a phase
2025 ASCO
Meetings / Conferences
Phase 3 VERIFY study shows rusfertide significantly improves PV outcomes over SOC
In patients with polycythemia vera (PV) receiving standard of care (SOC) therapy, treatment with rusfertide resulted in a statistically significant reduction in the
Myeloproliferative Neoplasms
SOHO Insider Podcast
Drs. Kuykendall and Hobbs on MPN care in 2025
Watch the podcast on YouTube. Andrew Kuykendall, MD, of Moffitt Cancer Center in Tampa, Florida, hosts a podcast on the latest news in
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
News
NCCN recommends pemivibart for BCL patients at risk of severe COVID-19
Many patients with B-cell lymphomas experience reduced vaccine efficacy and may not mount an adequate immune response to vaccination, putting them at elevated
2025 ASCO
Meetings / Conferences
Early palliative care integration does not reduce MM patients’ healthcare utilization
Early integration of palliative care does not reduce the use of healthcare resources by patients with newly diagnosed multiple myeloma (MM) compared to